Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company. The Company is focused on developing and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. It also owns interests in certain commercial real estate assets. The Company conducts business as two operating segments, Pharmaceuticals and Real Estate.